Robert West

Author PubWeight™ 298.78‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implement Sci 2011 11.79
2 Time for a change: putting the Transtheoretical (Stages of Change) Model to rest. Addiction 2005 8.61
3 An invitation to an alcohol industry lobby to help decide public funding of alcohol research and professional training: a decision that should be reversed. Addiction 2004 5.61
4 Why evidence for the fetal origins of adult disease might be a statistical artifact: the "reversal paradox" for the relation between birth weight and blood pressure in later life. Am J Epidemiol 2005 4.81
5 Randomized controlled trial of a web-based computer-tailored smoking cessation program as a supplement to nicotine patch therapy. Addiction 2005 3.95
6 Predictors of attempts to stop smoking and their success in adult general population samples: a systematic review. Addiction 2011 3.80
7 Attempts to quit smoking and relapse: factors associated with success or failure from the ATTEMPT cohort study. Addict Behav 2008 3.52
8 The integrity of the science base: a test case. Addiction 2005 3.40
9 Who is responsible for the public's health? The role of the alcohol industry in the WHO global strategy to reduce the harmful use of alcohol. Addiction 2013 3.24
10 The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans. J Exp Med 2009 3.17
11 Strength of urges to smoke as a measure of severity of cigarette dependence: comparison with the Fagerström Test for Nicotine Dependence and its components. Addiction 2010 2.87
12 Development of a taxonomy of behaviour change techniques used in individual behavioural support for smoking cessation. Addict Behav 2010 2.78
13 Real-world effectiveness of e-cigarettes when used to aid smoking cessation: a cross-sectional population study. Addiction 2014 2.73
14 Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation. Proc Natl Acad Sci U S A 2006 2.72
15 Relapse prevention interventions for smoking cessation. Cochrane Database Syst Rev 2009 2.58
16 Recommendation for the assessment of tobacco craving and withdrawal in smoking cessation trials. Nicotine Tob Res 2004 2.34
17 Smoking prevalence in England is below 20% for the first time in 80 years. BMJ 2014 2.31
18 Gradual Versus Abrupt Smoking Cessation: A Randomized, Controlled Noninferiority Trial. Ann Intern Med 2016 2.24
19 Identification of behaviour change techniques to reduce excessive alcohol consumption. Addiction 2012 2.21
20 Compulsory detention, forced detoxification and enforced labour are not ethically acceptable or effective ways to treat addiction. Addiction 2012 2.15
21 Should smokers be offered assistance with stopping? Addiction 2010 2.07
22 Moderators and mediators of a web-based computer-tailored smoking cessation program among nicotine patch users. Nicotine Tob Res 2006 2.01
23 Prevention of relapse after quitting smoking: a systematic review of trials. Arch Intern Med 2006 1.88
24 What makes for an effective stop-smoking service? Thorax 2011 1.87
25 A compact VEGF signature associated with distant metastases and poor outcomes. BMC Med 2009 1.84
26 Failure to report attempts to quit smoking. Addict Behav 2010 1.80
27 Brief opportunistic smoking cessation interventions: a systematic review and meta-analysis to compare advice to quit and offer of assistance. Addiction 2012 1.80
28 Cytisine for smoking cessation: a research agenda. Drug Alcohol Depend 2007 1.70
29 Patellar resurfacing in total knee arthroplasty: does design matter? A meta-analysis of 7075 cases. J Bone Joint Surg Am 2011 1.69
30 'The smoking toolkit study': a national study of smoking and smoking cessation in England. BMC Public Health 2011 1.68
31 The most "successful" method for failing to quit smoking is unassisted cessation. Nicotine Tob Res 2012 1.67
32 Factors associated with the use of aids to cessation in English smokers. Addiction 2009 1.65
33 Distinct neural circuits support transient and sustained processes in prospective memory and working memory. Cereb Cortex 2008 1.63
34 Relapse to smoking during unaided cessation: clinical, cognitive and motivational predictors. Psychopharmacology (Berl) 2010 1.62
35 'Real-world' effectiveness of smoking cessation treatments: a population study. Addiction 2013 1.60
36 PML-RARA-targeted DNA vaccine induces protective immunity in a mouse model of leukemia. Nat Med 2003 1.60
37 Assessing smoking status in children, adolescents and adults: cotinine cut-points revisited. Addiction 2008 1.59
38 Identifying evidence-based competences required to deliver behavioural support for smoking cessation. Ann Behav Med 2011 1.58
39 Unplanned quit attempts--results from a U.S. sample of smokers and ex-smokers. Nicotine Tob Res 2009 1.57
40 The clinical significance of "small" effects of smoking cessation treatments. Addiction 2007 1.57
41 Changes in smoking prevalence in 16-17-year-old versus older adults following a rise in legal age of sale: findings from an English population study. Addiction 2010 1.55
42 Early dating predicts smoking during adolescence: A prospective study. Addiction 2006 1.55
43 Self-perceived smoking motives and their correlates in a general population sample. Nicotine Tob Res 2009 1.53
44 Managing smoking cessation. BMJ 2007 1.48
45 An evaluation of the diagnostic accuracy of liquid chromatography-tandem mass spectrometry versus immunoassay drug testing in pain patients. Pain Physician 2010 1.48
46 Drug trafficking: time to abolish the death penalty. Addiction 2009 1.41
47 Pathways, networks and choice in health care. Int J Health Care Qual Assur Inc Leadersh Health Serv 2006 1.40
48 Triggering anti-smoking advice by GPs: mode of action of an intervention stimulating smoking cessation advice by GPs. Patient Educ Couns 2005 1.37
49 The UK National Institute for Health and Clinical Excellence public health guidance on behaviour change: a brief introduction. Psychol Health Med 2009 1.35
50 Randomized controlled trial of a social support ('buddy') intervention for smoking cessation. Patient Educ Couns 2006 1.34
51 Providing web-based feedback and social norms information to reduce student alcohol intake: a multisite investigation. J Med Internet Res 2010 1.34
52 Imaging of Titan from the Cassini spacecraft. Nature 2005 1.34
53 Effectiveness of specialist group treatment for smoking cessation vs. one-to-one treatment in primary care. Addict Behav 2006 1.30
54 Motives for smoking and their correlates in clients attending Stop Smoking treatment services. Nicotine Tob Res 2008 1.29
55 A double-blind placebo controlled experimental study of nicotine: I--effects on incentive motivation. Psychopharmacology (Berl) 2006 1.28
56 Quit attempts in response to smoke-free legislation in England. Tob Control 2010 1.25
57 Enjoyment of smoking and urges to smoke as predictors of attempts and success of attempts to stop smoking: a longitudinal study. Drug Alcohol Depend 2010 1.24
58 Neurophysiological evidence of error-monitoring deficits in patients with schizophrenia. Cereb Cortex 2002 1.23
59 Relapse prevention interventions for smoking cessation. Cochrane Database Syst Rev 2013 1.22
60 Acute effect of a brief bout of exercise on alcohol urges. Addiction 2004 1.20
61 Behavior change techniques in popular alcohol reduction apps: content analysis. J Med Internet Res 2015 1.19
62 Efficacy of exercise counselling as an aid for smoking cessation: a randomized controlled trial. Addiction 2003 1.18
63 A mobile app to aid smoking cessation: preliminary evaluation of SmokeFree28. J Med Internet Res 2015 1.17
64 Patterns of change in withdrawal symptoms, desire to smoke, reward motivation and response inhibition across 3 months of smoking abstinence. Addiction 2009 1.17
65 The role of desire, duty and intention in predicting attempts to quit smoking. Addiction 2011 1.17
66 Effectiveness of varenicline versus nicotine replacement therapy for smoking cessation with minimal professional support: evidence from an English population study. Psychopharmacology (Berl) 2013 1.14
67 A double-blind placebo-controlled experimental study of nicotine: II--Effects on response inhibition and executive functioning. Psychopharmacology (Berl) 2007 1.14
68 Factors associated with higher body mass index, weight concern, and weight gain in a multinational cohort study of smokers intending to quit. Int J Environ Res Public Health 2009 1.13
69 Another mirror shattered? Tobacco industry involvement suspected in a book which claims that nicotine is not addictive. Addiction 2002 1.13
70 A systematic review of studies assessing the association between adherence to smoking cessation medication and treatment success. Addiction 2013 1.12
71 German medical students lack knowledge of how to treat smoking and problem drinking. Addiction 2012 1.08
72 Psychological interventions for coronary heart disease. Cochrane Database Syst Rev 2011 1.07
73 Did the introduction of varenicline in England substitute for or add to the use of other smoking cessation medications? Nicotine Tob Res 2011 1.07
74 Acute effect of isometric exercise on desire to smoke and tobacco withdrawal symptoms. Hum Psychopharmacol 2006 1.06
75 Gender differences in drinking practices in middle aged and older Russians. Alcohol Alcohol 2010 1.06
76 Nicotine intake in cigarette smokers in England: distribution and demographic correlates. Cancer Epidemiol Biomarkers Prev 2008 1.05
77 Medical students lack basic knowledge about smoking: findings from two European medical schools. Nicotine Tob Res 2009 1.02
78 BCL-2 and mutant NRAS interact physically and functionally in a mouse model of progressive myelodysplasia. Cancer Res 2007 1.02
79 Prevalence and characteristics of smokers interested in internet-based smoking cessation interventions: cross-sectional findings from a national household survey. J Med Internet Res 2013 1.02
80 Public support in England for raising the price of cigarettes to fund tobacco control activities. Tob Control 2010 1.01
81 Development of StopAdvisor: A theory-based interactive internet-based smoking cessation intervention. Transl Behav Med 2012 1.00
82 How does rate of smoking cessation vary by age, gender and social grade? Findings from a population survey in England. Addiction 2013 1.00
83 Factors associated with differences in quit rates between "specialist" and "community" stop-smoking practitioners in the english stop-smoking services. Nicotine Tob Res 2012 1.00
84 Assessing fidelity of delivery of smoking cessation behavioural support in practice. Implement Sci 2013 1.00
85 Effect of isometric exercise and body scanning on cigarette cravings and withdrawal symptoms. Addiction 2009 1.00
86 Physical activity as an aid to smoking cessation during pregnancy (LEAP) trial: study protocol for a randomized controlled trial. Trials 2012 1.00
87 Do ex-smokers report feeling happier following cessation? Evidence from a cross-sectional survey. Nicotine Tob Res 2009 1.00
88 Characterizing tobacco control mass media campaigns in England. Addiction 2013 0.99
89 Variations in stromal signatures in breast and colorectal cancer metastases. J Pathol 2010 0.99
90 Does it matter who you see to help you stop smoking? Short-term quit rates across specialist stop smoking practitioners in England. Addiction 2012 0.99
91 The impact of changing nicotine replacement therapy licensing laws in the United Kingdom: findings from the International Tobacco Control Four Country Survey. Addiction 2009 0.99
92 GP prescribing of nicotine replacement and bupropion to aid smoking cessation in England and Wales. Addiction 2004 0.99
93 The relationship between smokers' motivation to quit and intensity of tobacco control at the population level: a comparison of five European countries. BMC Public Health 2008 0.99
94 Drinking alcohol surrogates among clients of an alcohol-misuser treatment clinic in Novosibirsk, Russia. Subst Use Misuse 2009 0.98
95 Tobacco smoking in countries of the European Union. Ann Agric Environ Med 2012 0.98
96 Specifying evidence-based behavior change techniques to aid smoking cessation in pregnancy. Nicotine Tob Res 2012 0.97
97 Inorganic chemistry: Two-armed silicon. Nature 2012 0.97
98 Randomised cluster trial to support informed parental decision-making for the MMR vaccine. BMC Public Health 2011 0.96
99 A comparison of exposure to carcinogens among roll-your-own and factory-made cigarette smokers. Addict Biol 2009 0.96
100 Public support in England for a total ban on the sale of tobacco products. Tob Control 2010 0.96
101 A direct method and ICER tables for the estimation of the cost-effectiveness of smoking cessation interventions in general populations: application to a new cytisine trial and other examples. Nicotine Tob Res 2012 0.96
102 A negative association between video game experience and proactive cognitive control. Psychophysiology 2009 0.96
103 Very low rate and light smokers: smoking patterns and cessation-related behaviour in England, 2006-11. Addiction 2012 0.95
104 Comparison of the effectiveness of varenicline and combination nicotine replacement therapy for smoking cessation in clinical practice. Mayo Clin Proc 2013 0.95
105 Association between use of nicotine replacement therapy for harm reduction and smoking cessation: a prospective study of English smokers. Tob Control 2011 0.95
106 Effectiveness of over-the-counter nicotine replacement therapy. JAMA 2002 0.95
107 A survey of pregnant smokers' interest in different types of smoking cessation support. Patient Educ Couns 2004 0.94
108 Construction of a cyclin D1-Cdk2 fusion protein to model the biological functions of cyclin D1-Cdk2 complexes. J Biol Chem 2004 0.94
109 RCT of a client-centred, caseworker-delivered smoking cessation intervention for a socially disadvantaged population. BMC Public Health 2011 0.94
110 Randomized controlled trial of physical activity counseling as an aid to smoking cessation: 12 month follow-up. Addict Behav 2007 0.94
111 Association between nicotine replacement therapy use in pregnancy and smoking cessation. Drug Alcohol Depend 2013 0.94
112 The transcription factor LMO2 is a robust marker of vascular endothelium and vascular neoplasms and selected other entities. Am J Clin Pathol 2009 0.94
113 Developing a method for specifying the components of behavior change interventions in practice: the example of smoking cessation. J Consult Clin Psychol 2013 0.94
114 Neural correlates of spatial term use. J Exp Psychol Hum Percept Perform 2002 0.94
115 Smoking intentions and mood preceding lapse after completion of treatment to aid smoking cessation. Patient Educ Couns 2010 0.93
116 Fifty-two-week continuous abstinence rates of smokers being treated with varenicline versus nicotine replacement therapy. Addiction 2013 0.93
117 Varenicline versus transdermal nicotine patch: a 3-year follow-up in a smoking cessation clinic in Taiwan. Psychopharmacology (Berl) 2014 0.93
118 Risk factors for heterotopic ossification in primary total hip arthroplasty. Hip Int 2012 0.93
119 A pilot study of StopAdvisor: a theory-based interactive internet-based smoking cessation intervention aimed across the social spectrum. Addict Behav 2012 0.93
120 Positive smoker identity as a barrier to quitting smoking: findings from a national survey of smokers in England. Drug Alcohol Depend 2013 0.93
121 A cluster randomized controlled trial of a brief tobacco cessation intervention for low-income communities in India: study protocol. Addiction 2014 0.93
122 Identification of Behavior Change Techniques and Engagement Strategies to Design a Smartphone App to Reduce Alcohol Consumption Using a Formal Consensus Method. JMIR Mhealth Uhealth 2015 0.93
123 Prospective cohort study of the effectiveness of varenicline versus nicotine replacement therapy for smoking cessation in the "real world". BMC Public Health 2014 0.93
124 Providing full manuals and intervention descriptions: Addiction policy. Addiction 2008 0.92
125 To blow or not to blow: a randomised controlled trial of compression-only and standard telephone CPR instructions in simulated cardiac arrest. Resuscitation 2003 0.92
126 BCL-2 inhibition with ABT-737 prolongs survival in an NRAS/BCL-2 mouse model of AML by targeting primitive LSK and progenitor cells. Blood 2013 0.92
127 Bis[bis(trimethylsilyl)amino]silylene, an unstable divalent silicon compound. J Am Chem Soc 2003 0.92
128 Act now against new NHS competition regulations: an open letter to the BMA and the Academy of Medical Royal Colleges calls on them to make a joint public statement of opposition to the amended section 75 regulations. BMJ 2013 0.91
129 Smoking status of step-parents as a risk factor for smoking in adolescence. Addiction 2008 0.91
130 Neural correlates of stimulus and response interference in a 2-1 mapping stroop task. Int J Psychophysiol 2011 0.90
131 Long noncoding RNA EWSAT1-mediated gene repression facilitates Ewing sarcoma oncogenesis. J Clin Invest 2014 0.90
132 Does smoking in adolescence affect body mass index, waist or height? Findings from a longitudinal study. Addiction 2007 0.89
133 Beliefs about the harms of long-term use of nicotine replacement therapy: perceptions of smokers in England. Addiction 2012 0.89
134 Acute effects of a short bout of moderate versus light intensity exercise versus inactivity on tobacco withdrawal symptoms in sedentary smokers. Psychopharmacology (Berl) 2004 0.89
135 Stop smoking clinics in Malaysia: characteristics of attendees and predictors of success. Addict Behav 2010 0.89
136 Commentary on Smolkowski et al. (2010): why is it important to assume that non-responders in tobacco cessation trials have relapsed? Addiction 2010 0.89
137 Neurophysiological evidence for disturbances of conflict processing in patients with schizophrenia. J Abnorm Psychol 2003 0.89
138 Physical activity as an aid to smoking cessation during pregnancy: two feasibility studies. BMC Public Health 2008 0.88
139 Residual attraction to smoking and smoker identity following smoking cessation. Nicotine Tob Res 2010 0.88
140 How well is intervention content described in published reports of smoking cessation interventions? Nicotine Tob Res 2012 0.88
141 Reduction in cortisol after smoking cessation among users of nicotine patches. Psychosom Med 2006 0.88
142 Thinking about the unthinkable: a de facto prohibition on smoked tobacco products. Addiction 2008 0.88
143 The use of nicotine replacement therapy for smoking reduction and temporary abstinence: an interview study. Nicotine Tob Res 2011 0.87
144 Perceived barriers to and benefits of attending a stop smoking course during pregnancy. Patient Educ Couns 2005 0.87
145 Urge to smoke over 52 weeks of abstinence. Psychopharmacology (Berl) 2012 0.87
146 Neural correlates of prospective memory across the lifespan. Neuropsychologia 2007 0.87
147 Acceptability and effectiveness for withdrawal symptom relief of a novel oral nicotine delivery device: a randomised crossover trial. Psychopharmacology (Berl) 2011 0.87
148 Reporting quantitative information in qualitative research: guidance for authors and reviewers. Addiction 2014 0.86
149 Use of nicotine replacement therapy for smoking reduction and temporary abstinence: an update of beard et al. (2011). Addiction 2012 0.86
150 Self-reported practices, attitudes and levels of training of practitioners in the English NHS Stop Smoking Services. Addict Behav 2012 0.86
151 The needs and preferences of pregnant smokers regarding tailored Internet-based smoking cessation interventions: a qualitative interview study. BMC Public Health 2014 0.86
152 Dilute and shoot: analysis of drugs of abuse using selected reaction monitoring for quantification and full scan product ion spectra for identification. J Anal Toxicol 2012 0.86
153 The acute effects of yogic breathing exercises on craving and withdrawal symptoms in abstaining smokers. Psychopharmacology (Berl) 2012 0.86
154 Improved detection of ethyl glucuronide and ethyl sulfate in a pain management population using high-throughput LC-MS/MS. J Opioid Manag 2011 0.85
155 DNA vaccination with all-trans retinoic acid treatment induces long-term survival and elicits specific immune responses requiring CD4+ and CD8+ T-cell activation in an acute promyelocytic leukemia mouse model. Blood 2009 0.85
156 LC3-mediated fibronectin mRNA translation induces fibrosarcoma growth by increasing connective tissue growth factor. J Cell Sci 2009 0.85
157 Antimicrobial regime for cardiac surgery: the safety and effectiveness of short-course flucloxacillin (or teicoplanin) and gentamicin-based prophylaxis. J Card Surg 2013 0.85
158 An uncontrolled trial of cytisine (Tabex) for smoking cessation. Tob Control 2006 0.85
159 Hyperconjugative interactions in permethylated siloxanes and ethers: the nature of the SiO bond. J Am Chem Soc 2013 0.85
160 Novel delivery systems for nicotine replacement therapy as an aid to smoking cessation and for harm reduction: rationale, and evidence for advantages over existing systems. CNS Drugs 2013 0.85
161 Does smoking cessation cause depression and anxiety? Findings from the ATTEMPT cohort. Nicotine Tob Res 2011 0.85
162 Cardiovascular risk factors in patients with schizophrenia receiving continuous medical care. Community Ment Health J 2011 0.85
163 Rapid reduction versus abrupt quitting for smokers who want to stop soon: a randomised controlled non-inferiority trial. Trials 2009 0.84
164 Prospective randomized comparison of CarboMedics and St Jude Medical bileaflet mechanical heart valve prostheses: an interim report. J Thorac Cardiovasc Surg 2002 0.84
165 Differences in happiness between smokers, ex-smokers and never smokers: cross-sectional findings from a national household survey. Drug Alcohol Depend 2011 0.84
166 Neural correlates of cue retrieval, task set reconfiguration, and rule mapping in the explicit cue task switching paradigm. Psychophysiology 2008 0.84
167 The effect of reducing the threshold for carbon monoxide validation of smoking abstinence--evidence from the English Stop Smoking Services. Addict Behav 2013 0.84
168 Banning smoking in the workplace. BMJ 2002 0.83
169 An imperfect relationship between prospective memory and the prospective interference effect. Mem Cognit 2007 0.83
170 Drugs and harm to society. Lancet 2011 0.83
171 Is use of nicotine replacement therapy while continuing to smoke associated with increased nicotine intake? Evidence from a population sample. Psychopharmacology (Berl) 2011 0.83
172 Illicit drug use correlates with negative urine drug test results for prescribed hydrocodone, oxycodone, and morphine. Pain Physician 2012 0.83
173 CNTRICS imaging biomarker selections: Executive control paradigms. Schizophr Bull 2011 0.83
174 Randomized trial of nicotine replacement therapy (NRT), bupropion and NRT plus bupropion for smoking cessation: effectiveness in clinical practice. Addiction 2013 0.82
175 The influence of working memory load on the Simon effect. Psychon Bull Rev 2010 0.82
176 The attitude of maternity staff to, and smoking cessation interventions with, childbearing women in London. Midwifery 2005 0.82
177 Solid-state (29)Si NMR study of RSiSiR: a tool for analyzing the nature of the Si-Si bond. J Am Chem Soc 2006 0.82
178 Predictors of 3-month abstinence in smokers attending stop-smoking clinics in Malaysia. Nicotine Tob Res 2010 0.82
179 Evaluation of 3-day smoking cessation training course for doctors from 38 cities in China. Chin Med J (Engl) 2012 0.82
180 'Closet' quit attempts: prevalence, correlates and association with outcome. Addiction 2011 0.82
181 Tobacco industry lobbyists and their health-care clients. Lancet 2013 0.82
182 Cigarette craving and withdrawal symptoms during temporary abstinence and the effect of nicotine gum. Psychopharmacology (Berl) 2013 0.82
183 The association between chronic exposure to video game violence and affective picture processing: an ERP study. Cogn Affect Behav Neurosci 2011 0.81
184 German medical students' beliefs about the effectiveness of different methods of stopping smoking. Nicotine Tob Res 2013 0.81
185 What is the future of epidemiology? Lancet 2011 0.81
186 Tobacco use and dementia: evidence from the 1066 dementia population-based surveys in Latin America, China and India. Int J Geriatr Psychiatry 2011 0.81
187 Translating evidence-based guidelines into practice: a survey of practices of commissioners and managers of the English stop smoking services. BMC Health Serv Res 2012 0.81
188 Factors influencing late presentation for breast cancer in the middle East: a systematic review. Asian Pac J Cancer Prev 2011 0.81
189 Moving from theory to practice and back in social and health psychology. Health Psychol 2013 0.81
190 A randomized, controlled trial of adding expired carbon monoxide feedback to brief stop smoking advice: evaluation of cognitive and behavioral effects. Health Psychol 2011 0.80
191 What is the purpose of diagnosing addiction or dependence and what does this mean for establishing diagnostic criteria? Addiction 2011 0.80
192 Guidance for reporting qualitative manuscripts. Addiction 2015 0.80
193 Variation in saliva cotinine as a function of self-reported attempts to reduce cigarette consumption. Psychopharmacology (Berl) 2011 0.80
194 The effects of an action video game on visual and affective information processing. Brain Res 2013 0.79
195 Event-related neural activity associated with habit and recollection. Neuropsychologia 2002 0.79
196 Marijuana correlates with use of other illicit drugs in a pain patient population. Pain Physician 2010 0.79
197 Assessing the association between the use of NRT for smoking reduction and attempts to quit smoking using propensity score matching. Drug Alcohol Depend 2012 0.79
198 Impact of smoking cessation advice on future smoking behavior, morbidity, and mortality: up to 40 years of follow-up of the first randomized controlled trial of a general population sample. Arch Intern Med 2011 0.79
199 The use of videos to inform smokers about different nicotine replacement products. Patient Educ Couns 2003 0.79
200 Illicit drug use in the pain patient population decreases with continued drug testing. Pain Physician 2011 0.79
201 Transition towards a 'non-smoker' identity following smoking cessation: an interpretative phenomenological analysis. Br J Health Psychol 2011 0.79
202 Discovery of liver-targeted inhibitors of stearoyl-CoA desaturase (SCD1). Bioorg Med Chem Lett 2012 0.79
203 A new methodology for atrial flutter ablation by direct visualization of cavotricuspid conduction with voltage gradient mapping: a comparison to standard techniques. Europace 2013 0.78
204 Effectiveness of an online knowledge training and assessment program for stop smoking practitioners. Nicotine Tob Res 2012 0.78
205 How do prompts for attempts to quit smoking relate to method of quitting and quit success? Ann Behav Med 2014 0.78
206 Preventing tobacco companies from advertising using their packaging could be an important component of comprehensive tobacco control: a commentary on Australia's plain packaging of cigarettes. Drug Alcohol Rev 2011 0.78
207 Beliefs of stop smoking practitioners in United Kingdom on the use of nicotine replacement therapy for smoking reduction. Nicotine Tob Res 2011 0.78
208 A case-control study: are urological procedures risk factors for the development of infective endocarditis? BJU Int 2014 0.78
209 Associations between use of pharmacological aids in a smoking cessation attempt and subsequent quitting activity: a population study. Addiction 2014 0.78
210 Chest wall leiomyosarcoma after breast-conservative therapy for early-stage breast cancer in a young woman with Li-Fraumeni syndrome. J Natl Compr Canc Netw 2012 0.78
211 Breast Angiosarcoma: Case Series and Expression of Vascular Endothelial Growth Factor. Case Rep Oncol 2009 0.78
212 Effect of a GP desktop resource on smoking cessation activities of general practitioners. Addiction 2002 0.78
213 Identification of a dual histamine H1/H3 receptor ligand based on the H1 antagonist chlorpheniramine. Bioorg Med Chem Lett 2003 0.78
214 Can the Dutch Government really be abandoning smokers to their fate? Lancet 2011 0.78
215 Assessing Connections Between Behavior Change Theories Using Network Analysis. Ann Behav Med 2015 0.78
216 'Just another incentive scheme': a qualitative interview study of a local pay-for-performance scheme for primary care. BMC Fam Pract 2014 0.78
217 The Raman spectrum and aromatic stabilization in a cyclic germylene. J Am Chem Soc 2004 0.77
218 Age-related differences in the temporal dynamics of prospective memory retrieval: a lifespan approach. Neuropsychologia 2011 0.77
219 A randomized clinical trial of a financial education intervention with nicotine replacement therapy (NRT) for low socio-economic status Australian smokers: a study protocol. Addiction 2014 0.77
220 An improved method of determining ethanol use in a chronic pain population. J Opioid Manag 2011 0.77
221 Do implementation issues influence the effectiveness of medications? The case of nicotine replacement therapy and bupropion in UK Stop Smoking Services. BMC Public Health 2009 0.77
222 Effectiveness of nicotine replacement therapy--a rebuttal. Addiction 2012 0.77
223 The factor structure of the GHQ-12: the interaction between item phrasing, variance and levels of distress. Qual Life Res 2012 0.77
224 Validation of content of an online knowledge training program. Nicotine Tob Res 2012 0.77
225 Is the UK's coalition Government serious about public health? Lancet 2010 0.77
226 Word-list-learning performance in younger and older adults: intra-individual performance variability and false memory. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn 2007 0.76
227 Was the expansion of the marketing license for nicotine replacement therapy in the United kingdom to include smoking reduction associated with changes in use and incidence of quit attempts? Nicotine Tob Res 2013 0.76
228 Hypertension and its identification among current, past and never smokers in an English population sample. Eur J Cardiovasc Prev Rehabil 2010 0.76
229 A randomised placebo-controlled trial of oral hydrocortisone for treating tobacco withdrawal symptoms. Psychopharmacology (Berl) 2011 0.76
230 Variation in hospital admission for AMI unlikely to be attributable to smoking legislation. Eur Heart J 2007 0.76
231 What would my avatar do? Gaming, pathology, and risky decision making. Front Psychol 2013 0.76
232 Evaluation of high-resolution mass spectrometry for urine toxicology screening in a pain management setting. J Anal Toxicol 2012 0.76
233 Neural correlates of processing negative and sexually arousing pictures. PLoS One 2012 0.76
234 Helping patients in hospital to quit smoking. Dedicated counselling services are effective--others are not. BMJ 2002 0.76
235 Determination of medication cutoff values in a pain patient population. J Opioid Manag 2011 0.76
236 Animal Farm must give way to doublethink when studying addiction. Addiction 2014 0.75
237 Estimating the rate of usage of varenicline and other medication for smoking cessation. Addiction 2011 0.75
238 Study protocol: A cluster randomised controlled trial of implementation intentions to reduce smoking initiation in adolescents. BMC Public Health 2013 0.75
239 Assessing drug-related harm. Lancet 2007 0.75
240 Authors' reply to Roscoe. BMJ 2014 0.75
241 Association between smoking cessation and short-term health-care use: results from an international prospective cohort study (ATTEMPT). Addiction 2013 0.75
242 Cytisine and the failure to market and regulate for human health. Thorax 2013 0.75
243 Short vs. long bed rest after uncomplicated acute myocardial infarction: a systematic review and meta-analysis. J Clin Epidemiol 2004 0.75
244 Access to data from clinical trials sponsored by pharmaceutical companies. Addiction 2007 0.75
245 Does belief that one is addicted promote or deter attempts at abstinence? Addiction 2011 0.75
246 Addiction editors respond to Mr. Leverton. Addiction 2014 0.75
247 Response to reitan. Addiction 2013 0.75
248 Use of nicotine replacement therapy in situations involving temporary abstinence from smoking: a national survey of English smokers. Addict Behav 2012 0.75
249 Light smokers are less likely to receive advice to quit from their GP than moderate-to-heavy smokers: a comparison of national survey data from the Netherlands and England. Eur J Gen Pract 2013 0.75
250 Identification of a novel, orally bioavailable histamine H(3) receptor antagonist based on the 4-benzyl-(1H-imidazol-4-yl) template. Bioorg Med Chem Lett 2002 0.75
251 A renewed call for action on alcohol policy. Addiction 2010 0.75
252 The negative ion photoelectron spectrum of cyclopropane-1,2,3-trione radical anion, (CO)3(•-)--a joint experimental and computational study. J Am Chem Soc 2014 0.75
253 Improvement of pain physicians' practices of opioid management: population-based urinary excretion data. J Opioid Manag 2012 0.75
254 Formation of disilanes in the reaction of stable silylenes with halocarbons. J Am Chem Soc 2005 0.75
255 Diurnal variations in first lapses to smoking for nicotine patch users. Hum Psychopharmacol 2003 0.75
256 Announcing changes to randomized controlled trial (RCT) registration requirements and our new Short Report format. Addiction 2016 0.75
257 Unusual reaction of 1,1-dilithio-2,3,4,5-tetraphenylsilole with 1,3-dienes yielding spirosilanes and elemental lithium. Angew Chem Int Ed Engl 2006 0.75
258 Bicyclic and tricyclic heterocycle derivatives as histamine H3 receptor antagonists for the treatment of obesity. Bioorg Med Chem Lett 2013 0.75
259 Generation and aromaticity of 2-silaimidazolium ion, a new pi-conjugated silylium ion. Chem Commun (Camb) 2004 0.75
260 Ring-shaped silafluorene derivatives as efficient solid-state UV-fluorophores: synthesis, characterization, and photoluminescent properties. Chemistry 2014 0.75
261 Research methods and statistical techniques in addiction. Addiction 2012 0.75
262 The case of Stop Smoking Services in England. Br J Psychiatry 2013 0.75
263 [Bis(trimethylsilyl)amido-kappaN]{tert-butyl[(E)-2-(tert-butylimino)ethyl]amido-kappa(2)N,N'}tin(II), a key intermediate in the synthesis of 1,3-di-tert-butyl-2,3-dihydro-1H-1,3,2-diazastannole. Acta Crystallogr C 2006 0.75
264 Adolescents' awareness of, and involvement with, illicit tobacco in the UK. Tob Control 2010 0.75
265 Radical reactions of a stable N-heterocyclic silylene: EPR study and DFT calculation. J Am Chem Soc 2004 0.75
266 Free radical reactivity of mono- and dichlorosilylene with muonium. Chemistry 2011 0.75
267 A disilapentalene and a stable diradical from the reaction of a dilithiosilole with a dichlorocyclopropene. J Am Chem Soc 2003 0.75
268 AEE-active cyclic tetraphenylsilole derivatives with ∼100% solid-state fluorescence quantum efficiency. Dalton Trans 2015 0.75
269 German medical students' beliefs about how best to treat alcohol use disorder. Eur Addict Res 2013 0.75
270 Radical reactions of a stable N-heterocyclic germylene: EPR study and DFT calculation. J Am Chem Soc 2005 0.75
271 Reference intervals: a novel approach to detect drug abuse in a pain patient population. J Opioid Manag 2010 0.75
272 Synthesis of a silene from 1,1-dilithiosilole and 2-adamantanone. J Am Chem Soc 2004 0.75
273 Synthesis of highly fluorescent diquinaldinatoalumino silole derivatives. Chemistry 2013 0.75
274 LC-MS/MS extends the range of drug analysis in pain patients. Ther Drug Monit 2009 0.75
275 Self-assembly of N-heterocyclic derivatives of divalent germanium, tin, and lead. Chemistry 2014 0.75
276 A silyl radical formed by muonium addition to a silylene. Angew Chem Int Ed Engl 2010 0.75
277 Reaction of stable N-heterocyclic silylenes and germylenes with muonium. Chemistry 2009 0.75
278 High solid-state fluorescence in ring-shaped AEE-active tetraphenylsilole derivatives. Chem Commun (Camb) 2014 0.75
279 6-Acetylmorphine detected in the absence of morphine in pain management patients. Ther Drug Monit 2009 0.75
280 Current issues and new directions in Psychology and Health: the potential contribution of health psychology to developing effective interventions to reduce tobacco smoking. Psychol Health 2010 0.75
281 Junior doctors' understanding of alcohol units remains poor. Clin Med 2014 0.75
282 Chemistry of the aromatic 9-germafluorenyl dianion and some related silicon and carbon species. J Am Chem Soc 2002 0.75
283 Halophilic reactions of a stable silylene with chloro and bromocarbons. J Am Chem Soc 2002 0.75
284 The synthesis of substituted fluorenes as novel non-imidazole histamine h(3) inhibitors. Bioorg Med Chem Lett 2002 0.75
285 Unstable propoxyphene metabolite excreted in human urine is detected by liquid chromatography-tandem mass spectrometry. J Anal Toxicol 2009 0.75
286 Structure and chemistry of 1-silafluorenyl dianion, its derivatives, and an organosilicon diradical dianion. J Am Chem Soc 2002 0.75
287 Should public health bodies stop commissioning research from market research companies that serve the tobacco industry? Addiction 2013 0.75
288 GPs have key role in helping patients to stop smoking. Practitioner 2012 0.75
289 Acute reduction in secretory immunoglobulin A following smoking cessation. Psychoneuroendocrinology 2004 0.75
290 News committee for the Society for Research on Nicotine and Tobacco Treatment Network: policy issues. Nicotine Tob Res 2014 0.75
291 Probing the reactivity of a stable silene using muonium. Angew Chem Int Ed Engl 2008 0.75
292 Data Notes Series. Addiction 2016 0.75
293 Stability of pain-related medications, metabolites, and illicit substances in urine. Clin Chim Acta 2012 0.75
294 TRUK: Tobacco Research UK. Addiction 2004 0.75
295 A bis(silaselenone) with two donor-stabilized Si=Se bonds from an unexpected stereoconvergent hydrolysis of a diselenadisiletane. Angew Chem Int Ed Engl 2009 0.75
296 Can stopping smoking cause hypertension? Nicotine Tob Res 2002 0.75
297 Contribution of cardiac rehabilitation in the management of patients following acute myocardial infarction. Future Cardiol 2012 0.75